Drug Gets Kinase Back to Work in Parkinson's Disease
By Anette Breindl
Monday, August 19, 2013
As far as targeting kinases goes, inhibition is the only game in town. But that is not because there's no need for activators. Kinases that no longer work like they should play a role in diseases including diabetes, cancer and Parkinson's disease. In the latter case, the kinase in question is PINK1. PINK1 is found in mitochondria, where its functioning is important to keep them healthy. Mutations in the PINK1 gene that reduce the enzyme's activity can lead to early onset Parkinson's disease.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.